BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6887199)

  • 21. Potential antitumor agents. 37. Organophosphorus derivatives of 9-anilinoacridine.
    Rewcastle GW; Baguley BC; Cain BF
    J Med Chem; 1982 Oct; 25(10):1231-5. PubMed ID: 7143362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative effects of hycanthone in Schistosoma mansoni and Schistosoma japonicum.
    Hillman GR; Gibler WB; Anderson JB
    Am J Trop Med Hyg; 1977 Mar; 26(2):238-42. PubMed ID: 848646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical studies on beta-glucuronidase in the urinary bladder of normal and Schistosoma mansoni infected mice treated with hycanthone.
    Saad AA; El-Zoghby SM; Farag HF; el-Sewedy SM; Girgis LH; Moghazy M
    Acta Vitaminol Enzymol; 1977; 31(6):183-6. PubMed ID: 581137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and antitumor properties of N1-acyloxymethyl derivatives of bis(2,6-dioxopiperazines).
    Cai JC; Shu HL; Tang CF; Komatsu T; Matsuno T; Narita T; Yaguchi S; Koide Y; Takase M
    Chem Pharm Bull (Tokyo); 1989 Nov; 37(11):2976-83. PubMed ID: 2632042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antileukemic activity of derivatives of 1,2-dimethyl-3,4-bis(hydroxymethyl)-5-phenylpyrrole bis(N-methylcarbamate).
    Anderson WK; Halat MJ
    J Med Chem; 1979 Aug; 22(8):977-80. PubMed ID: 490542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase I study of hycanthone.
    Kovach JS; Moertel CG; Schutt AJ; Eagan RT
    Cancer Treat Rep; 1979; 63(11-12):1965-9. PubMed ID: 526930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of schistosomiasis mansoni with hycanthone (our experience in 3,500 cases)].
    Huggins D
    G E N; 1978; 32(3):295-301. PubMed ID: 110648
    [No Abstract]   [Full Text] [Related]  

  • 28. Synthesis and antineoplastic activity of mitosene analogues of the mitomycins.
    Hodges JC; Remers WA; Bradner WT
    J Med Chem; 1981 Oct; 24(10):1184-91. PubMed ID: 7328580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Resistance to hycanthone and oxamniquine in patients with a clinical hepato-intestinal form of schistosomiasis].
    Guimarães RX; Tchakerian A; Dias LC; de Almeida FM; Vilela MP; Cabeca M; Takeda AK
    AMB Rev Assoc Med Bras; 1979 Feb; 25(2):48-50. PubMed ID: 314642
    [No Abstract]   [Full Text] [Related]  

  • 30. Use of praziquantel in patients with schistosomiasis mansoni previously treated with oxamniquine and/or hycanthone: resistance of Schistosoma mansoni to schistosomicidal agents.
    de Souza Dias LC; de Jesus Pedro R; Deberaldini ER
    Trans R Soc Trop Med Hyg; 1982; 76(5):652-9. PubMed ID: 7179419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative molecular field analysis of the antitumor activity of 9H-thioxanthen-9-one derivatives against pancreatic ductal carcinoma 03.
    Horwitz JP; Massova I; Wiese TE; Besler BH; Corbett TH
    J Med Chem; 1994 Mar; 37(6):781-6. PubMed ID: 8145227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum enzymatic changes in patients with schistosomiasis treated with oxamniquine or hycanthone. Comparative study.
    Saéz-Alquézar A; Ohtsuki N; Sette Júnior H; Magnanelli AC; Raia S; da Silva LC
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):105-10, 225-31. PubMed ID: 7455503
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical evaluation of niridazole and hycanthone in schistosomiasis mansoni endemic areas.
    Katz N
    J Toxicol Environ Health; 1975 Nov; 1(2):203-9. PubMed ID: 1107578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical treatment of schistosomiasis mansoni with a new schistosomicidal agent: hycanthone or etrenol.
    Sotomayor ZR; Febles F; Ramos Morales F; Sanchez G; Rivera M
    J Trop Med Hyg; 1976 Jan; 79(1):18-21. PubMed ID: 772233
    [No Abstract]   [Full Text] [Related]  

  • 35. Early steps in mutagenesis by hycanthone.
    Bases R; Mendez F; Elequin F; Liebeskind D; Kozin A; Neubort S
    Cancer Res; 1978 Mar; 38(3):781-6. PubMed ID: 626982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunoglobulins level in patients with schistosomiasis mansoni after hycanthone treatment].
    Curiel M
    G E N; 1977; 32(2):141-51. PubMed ID: 97156
    [No Abstract]   [Full Text] [Related]  

  • 37. Acute and early chronic phases of schistosomiasis mansoni in children treated with hycanthone.
    Tonelli E; Penna FJ; Leão E; Miranda D
    Acta Gastroenterol Latinoam; 1975 Jul; 6(3):125-36. PubMed ID: 1179940
    [No Abstract]   [Full Text] [Related]  

  • 38. [Electrocardiographic changes in patients with schistosomiasis mansoni treated with hycanthone].
    Takaoka L; Baldy JL; Passos JD; Soares EC; Zeitune JM; Siqueira JE
    Rev Inst Med Trop Sao Paulo; 1976; 18(5):378-86. PubMed ID: 1006067
    [No Abstract]   [Full Text] [Related]  

  • 39. Heterocyclic quinones with potential antitumor activity. 2. Synthesis and antitumor activity of some benzimidazole-4,7-dione derivatives.
    Antonini I; Claudi F; Cristalli G; Franchetti P; Grifantini M; Martelli S
    J Med Chem; 1988 Jan; 31(1):260-4. PubMed ID: 3336025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A controlled trial of hycanthone and placebo in schistosomiasis mansoni in St. Lucia.
    Cook JA; Jordan P; Woodstock L; Pilgrim V
    Ann Trop Med Parasitol; 1977 Jun; 71(2):197-202. PubMed ID: 326208
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.